97 results on '"Loprinzi, Charles L"'
Search Results
2. Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline
3. Fit for Chemo: Nerves May Thank You
4. Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial
5. ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer
6. A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia
7. 5-Year Follow-Up of a Randomized Controlled Trial of Immediate Versus Delayed Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Breast Cancer Starting Letrozole After Tamoxifen: N03CC (Alliance) Trial
8. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia
9. Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance)
10. Sequencing of Charcot–Marie–Tooth disease genes in a toxic polyneuropathy
11. North Central Cancer Treatment Group/Alliance trial N08CA—the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled study
12. The search for treatments to reduce chemotherapy-induced peripheral neuropathy
13. Wisconsin Ginseng (Panax quinquefolius) to Improve Cancer-Related Fatigue: A Randomized, Double-Blind Trial, N07C2
14. Further Data Supporting That Paclitaxel-Associated Acute Pain Syndrome Is Associated With Development of Peripheral Neuropathy: North Central Cancer Treatment Group Trial N08c1
15. Physical Activity and the Risk of Breast Cancer Recurrence: A Literature Review
16. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251)
17. Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC
18. Does hormonal therapy decrease tamoxifen associated hot flashes?
19. Patient-Physician Disagreement Regarding Performance Status Is Associated With Worse Survivorship in Patients With Advanced Cancer
20. Re: Randomized Controlled Trial to Evaluate Transdermal Testosterone in Female Cancer Survivors With Decreased Libido: North Central Cancer Treatment Group Protocol N02C3
21. Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia
22. Tetracycline to Prevent Epidermal Growth Factor Receptor Inhibitor-Induced Skin Rashes: Results of A Placebo-Controlled Trial From the North Central Cancer Treatment Group (N03cb)
23. Efficacy of Lamotrigine in the Management of Chemotherapy-Induced Peripheral Neuropathy: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial, N01c3
24. Aromatase inhibitors and tamoxifen: where do we go from here?
25. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: A phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3)
26. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: Results from N00C1 from the North Central Cancer Treatment Group
27. Phase II Evaluation of Desipramine for the Treatment of Hot Flashes
28. Randomized Controlled Trial to Evaluate Transdermal Testosterone in Female Cancer Survivors With Decreased Libido; North Central Cancer Treatment Group Protocol N02C3
29. Randomized Comparison of a Nicotine Inhaler and Bupropion for Smoking Cessation and Relapse Prevention
30. Whose Opinion Counts?
31. Pilot Evaluation of Aprepitant for the Treatment of Hot Flashes
32. Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Black Cohosh in the Management of Hot Flashes: NCCTG Trial N01CC1
33. Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial
34. Epoetin Alfa and Darbepoetin Alfa Go Head to Head
35. Hand-Foot Syndrome After Dose-Dense Adjuvant Chemotherapy for Breast Cancer: A Case Series
36. Phase III Comparison of Depomedroxyprogesterone Acetate to Venlafaxine for Managing Hot Flashes: North Central Cancer Treatment Group Trial N99C7
37. Phase III Study of Two Different Dosing Schedules of Erythropoietin in Anemic Patients With Cancer
38. Use of methylphenidate in patients with cancer
39. Two Concurrent Phase II Trials of Paclitaxel/Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252
40. Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline
41. Newer Antidepressants and Other Nonhormonal Agents for the Treatment of Hot Flashes
42. Erythropoietin Use in Cancer Patients: A Matter of Life and Death?
43. Evaluation of shark cartilage in patients with advanced cancer: A North Central Cancer Treatment Group trial
44. Cancer Patientsʼ and Patient Advocatesʼ Perspectives on a Novel Information Source: A Qualitative Study of The Art of Oncology, When the Tumor Is Not the Target
45. Eicosapentaenoic Acid: The Answers Are Not All In
46. As-Needed Morphine: Yes, but at What Dose and at What Interval?
47. Phase III, Randomized, Double-Blind Study of Epoetin Alfa Compared With Placebo in Anemic Patients Receiving Chemotherapy
48. Re: Pooled Analysis of Fluorouracil-Based Adjuvant Therapy of Stage II and III Colon Cancer: Who Benefits and by How Much?
49. Chemotherapy-Induced Ovarian Failure: Manifestations and Management
50. Pilot Evaluation of Paroxetine for Treating Hot Flashes in Men
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.